Engagement, Retention, and Progression to Type 2 Diabetes: A Retrospective Analysis of the Cluster-Randomised "Let's Prevent Diabetes" Trial

Attendance in a lifestyle and eating educational program is associated with a reduced incidence of diabetes Gray and colleagues reveal.

Vyšlo v časopise: Engagement, Retention, and Progression to Type 2 Diabetes: A Retrospective Analysis of the Cluster-Randomised "Let's Prevent Diabetes" Trial. PLoS Med 13(7): e32767. doi:10.1371/journal.pmed.1002078
Kategorie: Research Article
prolekare.web.journal.doi_sk: 10.1371/journal.pmed.1002078


Attendance in a lifestyle and eating educational program is associated with a reduced incidence of diabetes Gray and colleagues reveal.


1. National Cardiovascular Intelligence Network (NCVIN) (2015) NHS Diabetes Prevention Programme (NHS DPP) Non-diabetic hyperglycaemia. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/456149/Non_diabetic_hyperglycaemia.pdf

2. Morris DH, Webb D, Achana F, Srinivasan B, Gray LJ, et al. Progression rates from HbA1c 6.0–6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis. Diabetologia 2013;56(7):1489–1493. doi: 10.1007/s00125-013-2902-4 23584433

3. International Diabetes Federation (2015) IDF Diabetes Atlas—Seventh Edition.

4. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, et al. (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine 346: 393–403. 11832527

5. Lindström J, Louheranta A, Mannelin M, Rastas M, Salminen V, et al. (2003) The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 26: 3230–3236. 14633807

6. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, et al. (2006) The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1) Diabetologia 49: 289–297. 16391903

7. Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, et al. (2007) Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 334: 299. 17237299

8. Group TDPPR (2003) Costs Associated With the Primary Prevention of Type 2 Diabetes Mellitus in the Diabetes Prevention Program. Diabetes Care 26: 36–47. 12502656

9. Ashra N SR, Carter P, DAvies M, Dunkley A, Gillies C, Greaves C, Khunti K, Sutton S, Yates T, Youssef D, Gray LJ, (2015) A systematic review of the effectiveness of lifestyle interventions for the prevention of type 2 diabetes mellitus (T2DM) in routine practice. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/456147/PHE_Evidence_Review_of_diabetes_prevention_programmes-_FINAL.pdf

10. Davies M, Gray L, Ahrabian D, Leal J, Gray A, Troughton J, et al. A community based primary prevention programme for type 2 diabetes in the UK: A cluster randomised controlled trial. World Diabetes Congress 2015. 30 November-4 December. Abstract 1021-PD. http://www.idf.org/files/abstracts/data/HtmlApp/main.html#

11. Davies MJ, Gray LJ, Troughton J, Gray A, Tuomilehto J, et al. (2016) A community based primary prevention programme for type 2 diabetes integrating identification and lifestyle intervention for prevention: the Let's Prevent Diabetes cluster randomised controlled trial. Preventive Medicine 84: 48–56. doi: 10.1016/j.ypmed.2015.12.012 26740346

12. NHS (2014) Five year forward view. https://www.england.nhs.uk/wp-content/uploads/2014/10/5yfv-web.pdf.

13. Gray LJ, Khunti K, Williams S, Goldby S, Troughton J, et al. (2012) Let's Prevent Diabetes: study protocol for a cluster randomised controlled trial of an educational intervention in a multi-ethnic UK population with screen detected impaired glucose regulation. Cardiovascular Diabetology 11: 56. 22607160

14. Gray LJ, Khunti K, Edwardson C, Goldby S, Henson J, et al. (2012) Implementation of the automated Leicester Practice Risk Score in two diabetes prevention trials provides a high yield of people with abnormal glucose tolerance. Diabetologia 55: 3238–3244. doi: 10.1007/s00125-012-2725-8 23001376

15. Gray LJ, Davies MJ, Hiles S, Taub NA, Webb DR, et al. (2012) Detection of impaired glucose regulation and/or type 2 diabetes mellitus, using primary care electronic data, in a multiethnic UK community setting. Diabetologia 55: 959–966. doi: 10.1007/s00125-011-2432-x 22231125

16. World Health Organisation (1999) Definition, Diagnosis, and Classification of Diabetes Mellitus and its Complications. Report of a WHO consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organisation.

17. Troughton J, Chatterjee S, Hill SE, Daly H, Martin Stacey L, et al. (2015) Development of a lifestyle intervention using the MRC framework for diabetes prevention in people with impaired glucose regulation. Journal of Public Health. doi: 10.1093/pubmed/fdv110

18. World Health Organisation (2011) Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Geneva.

19. Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, et al. (2003) International physical activity questionnaire: 12-country reliability and validity. Medicine and Science in Sports and Exercise 35: 1381–1395. 12900694

20. Zigmond AS, Snaith RP (2006) The hospital anxiety and depression scale. Acta Psychiatr Scand 67: 361–370.

21. Sintonen H, Pekurinen M (1993) A fifteen-dimensional measure of health-related quality of life (15D) and its applications. In: Walker SR, Rosser RM, editors. Quality of Life Assessment: Key Issues in the 1990s. Dordrecht: Kluwer Academic Publishers. pp. 185–195.

22. Yates T, Davies M, Gorely T, Bull F, Khunti K (2009) Effectiveness of a pragmatic education programme aimed at promoting walking activity in individuals with impaired glucose tolerance: a randomized controlled trial. Diabetes Care 32: 1404–1410. doi: 10.2337/dc09-0130 19602539

23. Hayes RJ, Moulton LH (2009) Cluster randomised trials. Florida, USA: Chapman & Hall/CRC.

24. Jiang L, Manson SM, Beals J, Henderson WG, Huang H, et al. (2013) Translating the Diabetes Prevention Program Into American Indian and Alaska Native Communities: Results from the Special Diabetes Program for Indians Diabetes Prevention demonstration project. Diabetes Care 36: 2027–2034. doi: 10.2337/dc12-1250 23275375

25. Jackson SL, Long Q, Rhee MK, Olson DE, Tomolo AM, et al. (2015) Weight loss and incidence of diabetes with the Veterans Health Administration MOVE! lifestyle change programme: an observational study. The Lancet Diabetes & Endocrinology 3: 173–180.

26. Ali MK, Echouffo-Tcheugui JB, Williamson DF (2012) How Effective Were Lifestyle Interventions In Real-World Settings That Were Modeled On The Diabetes Prevention Program? Health Affairs 31: 67–75. doi: 10.1377/hlthaff.2011.1009 22232096

27. Penn L, Ryan V, White M (2013) Feasibility, acceptability and outcomes at a 12-month follow-up of a novel community-based intervention to prevent type 2 diabetes in adults at high risk: mixed methods pilot study. BMJ Open 3: e003585. doi: 10.1136/bmjopen-2013-003585 24227871

28. Cardona-Morrell M, Rychetnik L, Morrell SL, Espinel PT, Bauman A (2010) Reduction of diabetes risk in routine clinical practice: are physical activity and nutrition interventions feasible and are the outcomes from reference trials replicable? A systematic review and meta-analysis. BMC Public Health 10: 1–17.

29. Abraha I, Cherubini A, Cozzolino F, De Florio R, Luchetta ML, et al. (2015) Deviation from intention to treat analysis in randomised trials and treatment effect estimates: meta-epidemiological study. BMJ 350.

30. Wareham NJ Mind the gap: efficacy versus effectiveness of lifestyle interventions to prevent diabetes. The Lancet Diabetes & Endocrinology 3: 160–161.

31. Brueton VC, Tierney JF, Stenning S, Meredith S, Harding S, et al. (2014) Strategies to improve retention in randomised trials: a Cochrane systematic review and meta-analysis. BMJ Open 4: e003821. doi: 10.1136/bmjopen-2013-003821 24496696

Interné lekárstvo

Článok vyšiel v časopise

PLOS Medicine

2016 Číslo 7
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle

Zvýšte si kvalifikáciu online z pohodlia domova

Eozinofilní granulomatóza s polyangiitidou
nový kurz

Betablokátory a Ca antagonisté z jiného úhlu
Autori: prof. MUDr. Michal Vrablík, Ph.D., MUDr. Petr Janský

Autori: doc. MUDr. Petr Čáp, Ph.D.

Farmakoterapie akutní a chronické bolesti

Získaná hemofilie - Povědomí o nemoci a její diagnostika

Všetky kurzy
Zabudnuté heslo

Nemáte účet?  Registrujte sa

Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.


Nemáte účet?  Registrujte sa